HOME >> BIOLOGY >> NEWS
New research puts a fresh spin on current thinking of speech evolution in humans

Montreal, June 30, 2005. A study, published today in the prestigious journal Nature by Dr. Michael Petrides and colleagues at the Montreal Neurological Institute (MNI) at McGill University, challenges current thinking that speech developed as a result of new structures that evolved in the human brain. Dr. Petrides and colleagues have identified a distinct brain region that controls jaw movements in macaque monkeys that is comparable to Broca's area - the region in the human brain critical for speech production. This discovery is important as it suggests that this area of the brain evolved originally to perform high-order control over the mouth and the jaw, and that as humans evolved this area came to control the movements necessary for speech.

"Our study shows that nonlinguistic monkeys possess an area comparable to Broca's area it is located in the same region and has the same anatomical characteristics as Broca's area in the human brain", explained Dr. Michael Petrides, Coordinator of the Cognitive Neuroscience Unit at the MNI and Professor in the Department of Neurology and Neurosurgery, McGill University.

"The researchers performed quantitative microscopic analysis of the cytoarchitecture of the region of interest and electrophysiological stimulation and recording within this region.

When this area in the monkey was electrically stimulated, oral and facial motor responses were evoked such as jaw movement sequences, as well as respiratory responses. In addition, Broca's area is connected with a region of the brain immediately in front of it that is involved in the retrieval of information from memory.

"These connections suggest to us that Broca's area is in a unique position to use information shared from past experience and which is stored in memory for the service of communicative acts," explains Dr. Petrides. "That is, Broca's area may have evolved originally as an area exercising high-level control over oral and fa
'"/>

Contact: Sandra McPherson
sandra.mcpherson@mcgill.ca
514-398-1902
McGill University
29-Jun-2005


Page: 1 2

Related biology news :

1. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
2. Saudi Arabias KAUST names WHOI first research partner
3. Multinational research: protecting ecology means understanding people, too
4. Newly created cancer stem cells could aid breast cancer research
5. Carnegie Mellons Peter Adams receives EPA research grant
6. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
7. Innovative tagging technique may help researchers better protect fish stocks
8. Penn researchers discover how key protein stops inflammation
9. UCF research links proteins, stem cells and potential Alzheimers treatment
10. ASU researchers partner with UOP to make biofuel for military jets a reality
11. Einstein researchers prototype vaccine could provide improved protection against tuberculosis

Post Your Comments:
(Date:5/20/2013)... antibiotic colistin are also commonly resistant to antimicrobial ... a study in mBio , the online ... Cross-resistance to colistin and host antimicrobials LL-37 and ... attack, could mean that patients with life-threatening multi-drug ... immune response. Colistin is a last-line drug for ...
(Date:5/20/2013)... effect of physical education (PE) on child weight, but ... the amount of time that elementary schoolchildren spent in ... study represents some of the first evidence of a ... forthcoming in the Journal of Health Economics . ... be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The research ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3Gym class reduces probability of obesity, study finds for first time 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
(Date:5/21/2013)... Clear Lake, MN (PRWEB) May 21, 2013 ... all-in-one trade show display solution for sales and marketing teams ... GLM Displays describes the kit as “everything you’ll need ... The Fusion Fabric Display Kit comes with a number of ... an all-around trade booth 20 feet by 20 feet in ...
(Date:5/20/2013)... , Collaboration with the ... in treatment of mastitis , ... to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate ... Service (ARS) to develop and trial products targeting the ...
(Date:5/20/2013)... Oven Industries Inc. announces a new laboratory ... controller has many outstanding user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... be used universally, which allows the user to use ...
(Date:5/20/2013)... , May 20, 2013 Today, at ... San Francisco , James McGough ... Psychiatry at the Semel Institute for Neuroscience and Human ... of Medicine at the University of California Los Angeles ... Child and Adolescent Psychopharmacology and ADHD at UCLA, presented ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
Cached News: